Abacavir, dolutegravir, and lamivudine and Hepatitis
Result of checking the interaction of drug Abacavir, dolutegravir, and lamivudine and disease Hepatitis for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Patients with underlying hepatitis B or C may be at increased risk for worsening or development of transaminase elevations with the use of dolutegravir. In some cases there was hepatitis B reactivation particularly in a setting where anti- hepatitis treatment was withdrawn. Appropriate laboratory testing prior to initiating treatment and monitoring for hepatotoxicity during therapy is recommended in patients with underlying hepatitis B or C.
Generic Name: abacavir / dolutegravir / lamivudine
Brand Name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Abacavir, dolutegravir, and lamivudine - zapalenie wątroby 
Abacavir, dolutegravir, and lamivudine - hepatite 
Abacavir, dolutegravir, and lamivudine - hepatitis 
Abacavir, dolutegravir, and lamivudine - hepatitis 
Abacavir, dolutegravir, and lamivudine - epatite 
Abacavir, dolutegravir, and lamivudine - hépatite 
Abacavir, dolutegravir, and lamivudine - Hepatitis 
Abacavir, dolutegravir, and lamivudine - hepatitis 
Abacavir, dolutegravir, and lamivudine - гепатит 
Abacavir, dolutegravir, and lamivudine - hepatit 
Abacavir, dolutegravir, and lamivudine - التهاب الكبد 
Abacavir, dolutegravir, and lamivudine - 肝炎